iacp's 20th annual compounders
on capitol hill
400 Attendees Convene in Washington, D.C. for the 20th Annual Compounders on Capitol Hill
The United Voice of Compounders Is Heard!
A special thanks to all the IACP members who participated either in person at Compounders on Capitol Hill,
held, May 17-20, 2014 in Washington, D.C., or via our Virtual Hill Day
-- your efforts made a HUGE impact. And a fast one as well. One of our
key messages to Senators and Congressmen was that the U.S. Food and Drug Administration (FDA's) interpretation of the 2013 Drug Quality & Security Act (DQSA)
appears to ignore Congressional intent. Despite repeated invitations
from IACP to speak with our CCH conference attendees, everyone at the
FDA was "unavailable" to attend and talk to those most impacted by the
agency's activities... and that was noticed by Congress.
U.S. Senator Lamar Alexander (R-Tenn.) announced that, at his request, the Senate Appropriations Committee
is directing the FDA to meet with doctors, patients, and pharmacists to
discuss their concerns about implementation of the compounding
legislation passed into law in November 2013.
“The purpose of
the compounding law is to end confusion and improve communication so we
can help prevent another tragic meningitis outbreak. If FDA isn’t
sitting down with doctors, patients and pharmacists and communicating
how it is implementing the law, then I will stay on FDA until it does.” – Lamar Alexander
Click here to read the U.S. Senate HELP Press Release.
and its legislative team have worked tirelessly for the past several
months emphasizing that FDA should be implementing DQSA according to
congressional intent. This issue was the primary basis of our CCH 2014
Asks. Click here to review these Asks.
Click here to read the complete CCH 2014 Report.
Click here to view the CCH 2014 Photo Gallery.